294 related articles for article (PubMed ID: 25481812)
1. Optimal glycaemic control in elderly people with type 2 diabetes: what does the evidence say?
Mathur S; Zammitt NN; Frier BM
Drug Saf; 2015 Jan; 38(1):17-32. PubMed ID: 25481812
[TBL] [Abstract][Full Text] [Related]
2. Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes.
Avogaro A; Dardano A; de Kreutzenberg SV; Del Prato S
Diabetes Obes Metab; 2015 Feb; 17(2):107-15. PubMed ID: 24867662
[TBL] [Abstract][Full Text] [Related]
3. What are the practical implications for treating diabetes in light of recent evidence? Updated recommendations from the Global Partnership for Effective Diabetes Management.
Bailey CJ; Blonde L; Del Prato S; Leiter LA; Nesto R;
Diab Vasc Dis Res; 2009 Oct; 6(4):283-7. PubMed ID: 20368223
[TBL] [Abstract][Full Text] [Related]
4. The individualisation of glycaemic targets in response to patient characteristics in type 2 diabetes: a scoping review.
Westall SJ; Narayanan RP; Watmough S; Irving G; Furlong N; McNulty S; Bujawansa S; Hardy K
Clin Med (Lond); 2022 May; 22(3):257-265. PubMed ID: 35443970
[TBL] [Abstract][Full Text] [Related]
5. Update on cognitive decline and dementia in elderly patients with diabetes.
Bordier L; Doucet J; Boudet J; Bauduceau B
Diabetes Metab; 2014 Nov; 40(5):331-7. PubMed ID: 24703603
[TBL] [Abstract][Full Text] [Related]
6. [Management of hyperglycaemia in type 2 diabetes: a patient-centered approach].
Scheen AJ; Mathieu C
Rev Med Liege; 2012 Dec; 67(12):623-31. PubMed ID: 23342872
[TBL] [Abstract][Full Text] [Related]
7. Risk of hypoglycaemia in people aged ≥65 years receiving linagliptin: pooled data from 1489 individuals with type 2 diabetes mellitus.
Nauck M; Araki A; Hehnke U; Plat A; Clark D; Khunti K
Int J Clin Pract; 2018 Oct; 72(10):e13240. PubMed ID: 30216648
[TBL] [Abstract][Full Text] [Related]
8. Hypoglycaemia in elderly patients with diabetes mellitus: causes and strategies for prevention.
Chelliah A; Burge MR
Drugs Aging; 2004; 21(8):511-30. PubMed ID: 15182216
[TBL] [Abstract][Full Text] [Related]
9. Medically minimising the impact of hypoglycaemia in type 2 diabetes: a review.
Noh RM; Graveling AJ; Frier BM
Expert Opin Pharmacother; 2011 Oct; 12(14):2161-75. PubMed ID: 21668402
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycaemia in the over 75s: Understanding the predisposing factors in type 2 diabetes (T2DM).
Heald AH; Anderson SG; Cortes GJ; Cholokova V; Narajos M; Khan A; Donnahey G; Livingston M
Prim Care Diabetes; 2018 Apr; 12(2):133-138. PubMed ID: 28941578
[TBL] [Abstract][Full Text] [Related]
11. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.
Miller ME; Bonds DE; Gerstein HC; Seaquist ER; Bergenstal RM; Calles-Escandon J; Childress RD; Craven TE; Cuddihy RM; Dailey G; Feinglos MN; Ismail-Beigi F; Largay JF; O'Connor PJ; Paul T; Savage PJ; Schubart UK; Sood A; Genuth S;
BMJ; 2010 Jan; 340():b5444. PubMed ID: 20061360
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Safety and Efficacy of Teneligliptin in Elderly Patients with Type 2 Diabetes: Subgroup Analysis of a 3-Year Post-Marketing Surveillance in Japan.
Kadowaki T; Haneda M; Ito H; Sasaki K; Yamada Y
Adv Ther; 2020 May; 37(5):2477-2492. PubMed ID: 32323194
[TBL] [Abstract][Full Text] [Related]
13. Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study.
Blicklé JF; Hancu N; Piletic M; Profozic V; Shestakova M; Dain MP; Jacqueminet S; Grimaldi A
Diabetes Obes Metab; 2009 Apr; 11(4):379-86. PubMed ID: 19087105
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced severe hypoglycaemia in Type 2 diabetic patients aged 80 years or older.
Greco D; Angileri G
Diabetes Nutr Metab; 2004 Feb; 17(1):23-6. PubMed ID: 15163121
[TBL] [Abstract][Full Text] [Related]
15. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
16. Gender-based differences in glycaemic control and hypoglycaemia prevalence in patients with type 2 diabetes: results from patient-level pooled data of six randomized controlled trials.
Kautzky-Willer A; Kosi L; Lin J; Mihaljevic R
Diabetes Obes Metab; 2015 Jun; 17(6):533-540. PubMed ID: 25678212
[TBL] [Abstract][Full Text] [Related]
17. Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL versus glargine 100 U/mL: A patient-level meta-analysis examining older and younger adults with type 2 diabetes.
Yale JF; Aroda VR; Charbonnel B; Sinclair AJ; Trescoli C; Cahn A; Bigot G; Merino-Trigo A; Brulle-Wohlhueter C; Bolli GB; Ritzel R
Diabetes Metab; 2020 Apr; 46(2):110-118. PubMed ID: 30366067
[TBL] [Abstract][Full Text] [Related]
18. Hypoglycaemia: an overview.
Graveling AJ; Frier BM
Prim Care Diabetes; 2009 Aug; 3(3):131-9. PubMed ID: 19782016
[TBL] [Abstract][Full Text] [Related]
19. Glycemic targets and medication limitations for type 2 diabetes mellitus in the older adult.
Thompson AM; Linnebur SA; Vande Griend JP; Saseen JJ
Consult Pharm; 2014 Feb; 29(2):110-23. PubMed ID: 24513421
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapy of type 2 diabetes mellitus in frail elderly patients.
Sathyanarayanan A; Rabindranathnambi A; Muraleedharan V
Br J Hosp Med (Lond); 2019 Nov; 80(11):C162-C165. PubMed ID: 31707876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
